Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BM-ASP-ICU: Diagnosing Invasive Aspergillosis in ICU Patients
NCT05138666Unknown
- Sponsor
- CHU de Besançon
- Start
- Sep 2022
- Primary completion
- Mar 2024
- Countries
- 1
01
Overview
Open-label, single-arm trial in Invasive Pulmonary Aspergillosis (IPA), sponsored by CHU de Besançon. Primary endpoint: Performance indicators of the algorithm at 90 days. Status: unknown.
02
Conditions
Invasive Pulmonary Aspergillosis (IPA)
Beyond the preview
Go deeper on NCT05138666.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05138666.